The Story

Commerce Family Eyecare offers myopia management, low vision care, and optical services—many of which require significant out-of-pocket spend. Before Cherry, the practice faced key barriers: a decline in myopia treatment starts after removing in-house payment plans, a requirement for full upfront payment creating a barrier to care, reliance on CareCredit as the only financing option, optical patients frequently walking out after hearing pricing, competition from Warby Parker and big box retailers, and pricing conversations that were primarily verbal, making affordability unclear. As a result, patients often showed interest—but hesitated or left when cost was introduced.

‍

The Goal

Myopia patients were delaying or declining treatment due to upfront cost, optical patients would disengage immediately after hearing price, staff lacked a consistent way to present affordability clearly, and financing wasn’t introduced effectively at the moment of hesitation. The core issue: patients were dropping off at the point of price.

‍

The Cherry Solution

Commerce Family Eyecare implemented Cherry to reintroduce payment flexibility, improve pricing conversations, and capture patients at the point of decision. Cherry allowed staff to present clear monthly payment options during conversations—helping patients immediately understand affordability. Opticians began using the Payment Estimator heavily when patients showed hesitation on price or frame or lens pricing created pushback, allowing staff to reframe pricing in real-time and keep patients engaged instead of losing them. By replacing rigid upfront payment requirements with flexible financing, patients regained access to treatment and the practice could confidently present higher-cost care options. Cherry was also embedded directly into the exam room experience using QR code displays, acrylic stands, and Cherry Payment Plans posters, making financing a standard part of every conversation.

‍

Results

Cherry helped Commerce Family Eyecare increase myopia treatment acceptance by 80%,with patients who previously delayed or declined treatment now moving forwardat significantly higher rates. Optical walkouts decreased by 10–15%, as fewer patients leave after hearing pricing—more stay engaged and consider their options. Optical sales increased by approximately 10%, as improved pricing conversations and reduced drop-off translated directly into revenue growth.Commerce Family Eyecare also drove $40K+ in Cherry volume in the first two months, across 20+ transactions, with continued pipeline growth, and recovered lost treatment starts that had previously been caused by requiring full upfront payment.

‍